Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Laminin 332 expression and prognosis in breast cancer.
Carpenter PM, Ziogas A, Markham EM, Cantillep AS, Yan R, Anton-Culver H. Carpenter PM, et al. Hum Pathol. 2018 Dec;82:289-296. doi: 10.1016/j.humpath.2018.08.003. Epub 2018 Aug 17. Hum Pathol. 2018. PMID: 30125583 Free PMC article.
Laminin 5 expression in metaplastic breast carcinomas.
Carpenter PM, Wang-Rodriguez J, Chan OT, Wilczynski SP. Carpenter PM, et al. Am J Surg Pathol. 2008 Mar;32(3):345-53. doi: 10.1097/PAS.0b013e3181592201. Am J Surg Pathol. 2008. PMID: 18300817
Diagnosis of prostate cancer using differentially expressed genes in stroma.
Jia Z, Wang Y, Sawyers A, Yao H, Rahmatpanah F, Xia XQ, Xu Q, Pio R, Turan T, Koziol JA, Goodison S, Carpenter P, Wang-Rodriguez J, Simoneau A, Meyskens F, Sutton M, Lernhardt W, Beach T, Monforte J, McClelland M, Mercola D. Jia Z, et al. Cancer Res. 2011 Apr 1;71(7):2476-87. doi: 10.1158/0008-5472.CAN-10-2585. Cancer Res. 2011. PMID: 21459804 Free PMC article.
Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.
Lindström LS, Yau C, Czene K, Thompson CK, Hoadley KA, Van't Veer LJ, Balassanian R, Bishop JW, Carpenter PM, Chen YY, Datnow B, Hasteh F, Krings G, Lin F, Zhang Y, Nordenskjöld B, Stål O, Benz CC, Fornander T, Borowsky AD, Esserman LJ; STO Trialists Group. Lindström LS, et al. Among authors: carpenter pm. J Natl Cancer Inst. 2018 Jul 1;110(7):726-733. doi: 10.1093/jnci/djx270. J Natl Cancer Inst. 2018. PMID: 29361175 Free PMC article.
Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.
Kuzucan A, Chen JH, Bahri S, Mehta RS, Carpenter PM, Fwu PT, Yu HJ, Hsiang DJ, Lane KT, Butler JA, Feig SA, Su MY. Kuzucan A, et al. Among authors: carpenter pm. Clin Breast Cancer. 2012 Apr;12(2):110-8. doi: 10.1016/j.clbc.2012.01.009. Clin Breast Cancer. 2012. PMID: 22444717 Free PMC article.
Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging.
Tromberg BJ, Zhang Z, Leproux A, O'Sullivan TD, Cerussi AE, Carpenter PM, Mehta RS, Roblyer D, Yang W, Paulsen KD, Pogue BW, Jiang S, Kaufman PA, Yodh AG, Chung SH, Schnall M, Snyder BS, Hylton N, Boas DA, Carp SA, Isakoff SJ, Mankoff D; ACRIN 6691 investigators. Tromberg BJ, et al. Among authors: carpenter pm. Cancer Res. 2016 Oct 15;76(20):5933-5944. doi: 10.1158/0008-5472.CAN-16-0346. Epub 2016 Aug 15. Cancer Res. 2016. PMID: 27527559 Free PMC article.
82 results